---
title: "Sol-Gel Technologies regains Nasdaq minimum bid price compliance after extension"
url: "https://aibio.space/news/sol-gel-technologies-regains-nasdaq-minimum-bid-price-compliance-after/"
publisher: "aibio.space (Biotech Investor Relations News)"
date: "2025-05-22"
section: "Listings"
tickers: "NASDAQ:SLGL"
source: "https://www.sec.gov/Archives/edgar/data/1684693/000117891325001925/zk2533255.htm"
summary: "Nasdaq confirmed on May 22, 2025 that the bid price deficiency matter is closed. The stock closed at $1.00 or more for 13 consecutive business days."
---

By the aibio.space news desk.

Sources

- [Sol-Gel Technologies Ltd. 6-K (2025-05-22)](https://www.sec.gov/Archives/edgar/data/1684693/000117891325001925/zk2533255.htm)

[SLGL](https://aibio.space/companies/sol-gel-technologies/)

2025-05-22

# Sol-Gel Technologies regains Nasdaq minimum bid price compliance after extension

Tickers [SLGL](https://aibio.space/companies/sol-gel-technologies/)

Nasdaq confirmed on May 22, 2025 that the bid price deficiency matter is closed. The stock closed at $1.00 or more for 13 consecutive business days.

## Key facts

- **Company**: Sol-Gel Technologies Ltd. (NASDAQ: SLGL)

- **News type**: Listings

- **Primary source**: [Sol-Gel Technologies Ltd. 6-K (2025-05-22)](https://www.sec.gov/Archives/edgar/data/1684693/000117891325001925/zk2533255.htm)

*The facade of a neoclassical court building at dusk. Photo: Carol M Highsmith, CC0, via rawpixel. The picture shows the field, not the companies named.*

Sol-Gel Technologies Ltd. (Nasdaq: [SLGL](https://aibio.space/companies/sol-gel-technologies/)) said it received a letter from Nasdaq on May 22, 2025 notifying it that it has regained compliance with the Nasdaq Minimum Bid Price Requirement. Nasdaq now considers the prior bid price deficiency matter closed.

A bid price deficiency means a stock has traded below the minimum price Nasdaq requires. On May 21, 2024, Nasdaq's Listing Qualifications staff had told the company that the bid price of its ordinary shares closed at less than $1 per share over the previous 30 consecutive business days, which did not comply with Listing Rule 5550(a)(2).

Nasdaq gave the company a 180 calendar day compliance period. On November 19, 2024, Nasdaq determined the company was eligible for an additional 180 calendar days, until May 19, 2025.

Nasdaq made its compliance determination after the closing bid price of the ordinary shares was $1.00 per share or greater for the last 13 consecutive business days, from May 5, 2025 through May 21, 2025.

[Report an error](https://aibio.space/reputation/#correction)

## Companies in this story

SLGL

Sol-Gel Technologies Ltd.

NASDAQ · Israel

Open the starter desk

## More in Listings

Listings

### [Propanc Biopharma faces Nasdaq delisting on bid price, plans to appeal](https://aibio.space/news/propanc-biopharma-faces-nasdaq-delisting-bid-price-plans-appeal/)

Oct 29, 2026

Listings

### [Reviva asks stockholders to approve reverse split of up to 1-for-100](https://aibio.space/news/reviva-asks-stockholders-approve-reverse-split-up-1-100/)

Oct 29, 2026

Listings

### [Nasdaq to delist Glucotrack shares after bid price exception ends](https://aibio.space/news/nasdaq-delist-glucotrack-shares-after-bid-price-exception-ends/)

Oct 28, 2026

---
Source page: https://aibio.space/news/sol-gel-technologies-regains-nasdaq-minimum-bid-price-compliance-after/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Sol-Gel Technologies regains Nasdaq minimum bid price compliance after extension", 2025-05-22, https://aibio.space/news/sol-gel-technologies-regains-nasdaq-minimum-bid-price-compliance-after/